Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer

Accomplished global commercial leader with deep expertise in retina drug launches Primary architect for the industry-defining launch of EYLEA® while at Regeneron Most recently served as Chief ...

Is Ocular Therapeutix’s (OCUL) New Commercial Hire Quietly Reframing Its Long‑Term Strategy?

In January 2026, Ocular Therapeutix announced that Chief Financial Officer and Chief Operating Officer Donald Notman had ...
The Pharma Letter

Ocular Therapeutix names David Robinson as global CCO

US ophthalmology specialist Ocular Therapeutix announced that David Robinson has agreed to join the company as global chief commercial officer (CCO).

Ocular Therapeutix, Inc.: Ocular Therapeutix Appoints David W. Robinson as Global Chief Commercial Officer

Accomplished global commercial leader with deep expertise in retina drug launches Primary architect for the industry-defining launch of EYLEA- while at Regeneron Most recently served as Chief Marketin ...